The scope of a class-action lawsuit targeting Organigram has been expanded to cover allegations that the cultivator’s pesticide-tainted medical marijuana made patients sick before it was recalled, according to CBC News.

The initial suit alleged that Organigram’s “design, development, testing, manufacturing, distribution, sale and marketing of its purported organic medical cannabis were negligent” and that the MMJ was “unsafe and harmful,” the news outlet reported.